Co-owned Portfolio
Oncology, Neurology, Immunology, CV/Metabolic
Discovery to ClinicalActive
Key Facts
Indication
Oncology, Neurology, Immunology, CV/Metabolic
Phase
Discovery to Clinical
Status
Active
Company
About Evotec
Evotec has evolved from a traditional CRO into a technology-enabled, fully integrated drug discovery and development partner. Its strategy leverages proprietary platforms like PanOmics and iPSC disease modeling, alongside flexible partnership models, to serve the entire Top 20 pharma and over 800 biotechs. Through its Just – Evotec Biologics division, it is also redefining biologics manufacturing with continuous processing to improve accessibility and affordability of therapies.
View full company profile